These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27761927)

  • 1. Hypercalcaemia-induced kidney injury caused by the vitamin D analogue calcitriol for psoriasis: a note of caution when prescribing topical treatment.
    Corden E; Higgins E; Smith C
    Clin Exp Dermatol; 2016 Dec; 41(8):899-901. PubMed ID: 27761927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment with 22-oxacalcitriol (OCT), a new vitamin D analogue, caused severe hypercalcemia with exacerbation of chronic renal failure in a psoriatic patient with diabetic nephropathy; a case report and analysis of the potential for hypercalcemia.
    Ohigashi S; Tatsuno I; Uchida D; Higurashi M; Hoshimoto S; Seki N; Hashimoto N; Saito Y
    Intern Med; 2003 Dec; 42(12):1202-5. PubMed ID: 14714959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcaemia and hypercalciuria after topical treatment of psoriasis with excessive amounts of calcipotriol.
    Georgiou S; Tsambaos D
    Acta Derm Venereol; 1999 Jan; 79(1):86. PubMed ID: 10086871
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcaemia with topical calcipotriol.
    Bourke JF; Berth-Jones J; Hutchinson PE
    BMJ; 1993 May; 306(6888):1344-5. PubMed ID: 8518595
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.
    Braun GS; Witt M; Mayer V; Schmid H
    Int J Dermatol; 2007 Dec; 46(12):1315-7. PubMed ID: 18173537
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamine D analogue-based therapies for psoriasis.
    O'Neill JL; Feldman SR
    Drugs Today (Barc); 2010 May; 46(5):351-60. PubMed ID: 20517536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs].
    Schmitt J; Meurer M
    Hautarzt; 2006 Aug; 57(8):679-84. PubMed ID: 16865352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of vitamin D analog use for the treatment of psoriasis.
    Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
    J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical treatment of psoriasis with calcipotriol. Report of clinical experience].
    Hofmann C; Schirle S
    Fortschr Med; 1993 Dec; 111(35-36):562-4. PubMed ID: 8307546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
    Gorgievska Sukarovska B; Lipozencić J
    Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
    Langner A; Ashton P; Van De Kerkhof PC; Verjans H
    Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study.
    Langner A; Verjans H; Stapór V; Mol M; Fraczykowska M
    Br J Dermatol; 1993 May; 128(5):566-71. PubMed ID: 8504051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcaemic crisis after excessive topical use of a vitamin D derivative.
    Hoeck HC; Laurberg G; Laurberg P
    J Intern Med; 1994 Mar; 235(3):281-2. PubMed ID: 8120527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol ointment: optimizing psoriasis therapy.
    Gold LF
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D analogues in psoriasis: effects on systemic calcium homeostasis.
    Bourke JF; Iqbal SJ; Hutchinson PE
    Br J Dermatol; 1996 Sep; 135(3):347-54. PubMed ID: 8949424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.